REP. BLILEY (R-VA.) REPLACING REP. DINGELL AS FDA PRIME MOVER ON CAPITOL HILL; TURNOVER IN COMMITTEES WILL BE ACCOMPANIED BY DEEP CUTS IN DEMOCRATIC STAFFS
Executive Summary
Rep. Bliley (R-Va.) -- a long-term ally of the pharmaceutical industry with a burning interest in the Kessler FDA -- appears likely to replace Rep. Dingell (D-Mich.) and/or Rep. Waxman (D- Calif.) as the Congressional overlord for FDA policy in the Republican 104th Congress.